The single-cell analysis market could span Animal, Human, and Microbial Cells. The market could be explored based on techniques as Polymerase Chain Reaction, Mass Spectroscopy, and Others. The key applications that could be explored in the single-cell analysis industry include Diagnostic and Research Applications. The single-cell analysis market could be explored by the end-user as Biotechnology and Biopharmaceutical Companies, Academic & Research Institutes, and Others.
North America is a leading region in the market. It is likely to maintain dominance in the forecast period owing to factors, such as the establishment of new biopharmaceutical and biotechnology products in the region. Furthermore, acceptance of gene-based analysis methods by these companies and research laboratories is increasing the regional market growth.
Download Free Sample - https://www.millioninsights.com/industry-reports/single-cell-analysis-market/request-sample
In addition, North America is followed by the Asia-Pacific region owing to several government initiatives undertaken to progress healthcare infrastructure, accessibility of skilled specialists to work advanced analytical instruments, and increasing healthcare spending.
Key players operating in the single-cell analysis industry include Abcam Plc., 10X Genomics, Agilent Technologies, Becton, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Dickinson, and Company, Illumina, Danaher Corporation, Bruker, GE Healthcare, Fluidigm Corporation, and Bio-Techne Corporation, among others. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures to boost the inorganic growth of the industry.
No comments:
Post a Comment